1. Home
  2. BCAR vs CYRX Comparison

BCAR vs CYRX Comparison

Compare BCAR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCAR

D. Boral ARC Acquisition I Corp. Class A Ordinary Shares

N/A

Current Price

$10.25

Market Cap

417.6M

Sector

Finance

ML Signal

N/A

CYRX

CryoPort Inc.

HOLD

Current Price

$10.17

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCAR
CYRX
Founded
2025
1999
Country
United States
United States
Employees
2
1100
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
417.6M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
BCAR
CYRX
Price
$10.25
$10.17
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.94
AVG Volume (30 Days)
285.3K
399.7K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
$7.19
Revenue Growth
N/A
N/A
52 Week Low
$9.89
$5.21
52 Week High
$10.65
$11.45

Technical Indicators

Market Signals
Indicator
BCAR
CYRX
Relative Strength Index (RSI) 74.90 72.51
Support Level $10.01 $9.18
Resistance Level $10.65 $10.23
Average True Range (ATR) 0.02 0.41
MACD 0.01 0.18
Stochastic Oscillator 87.50 94.55

Price Performance

Historical Comparison
BCAR
CYRX

About BCAR D. Boral ARC Acquisition I Corp. Class A Ordinary Shares

D Boral ARC Acquisition I Corp is a blank check company.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: